Pilot Study of Tissue and Hematopoietic Stem Cell Collection for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck Cancer
Phase of Trial: Phase II
Latest Information Update: 14 Jul 2017
At a glance
- Drugs Filgrastim (Primary)
- Indications Neutropenia
- Focus Therapeutic Use
- 14 Sep 2015 Planned End Date changed from 1 Jan 2019 to 1 Mar 2019 as reported by ClinicalTrials.gov.
- 14 Sep 2015 Planned primary completion date changed from 1 Jan 2018 to 1 Mar 2018 as reported by ClinicalTrials.gov.
- 09 Mar 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.